GGrantIndex
← Leaderboards

Donna L Bratton

National Jewish Health

$11,834,515
Attributed
$13,650,793
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$13,650,793 · 11

By mechanism

P01$6,678,768 · 6
R01$6,150,793 · 3
U01$504,232 · 1
R56$317,000 · 1

Top collaborators

Most similar at National Jewish Health

Same institution · by research overlap

Others in their field

Top investigators on “Macrophage

Research focus

MacrophageCellsInflammationSignal TransductionNeutrophilNadph OxidaseInfectionResolutionExcisionRecruitment ActivityPhagocytesChronicLeukocytesAutoimmunityApoptosisOxidantsRestorationIn VivoInvestigationCartoonsFunctional DisorderApoptoticChronic Granulomatous DiseaseOxidases

Grant awards (40)

Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD$628,494
R01 · FY2022 · AI · contact PI
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD$626,470
R01 · FY2021 · AI · contact PI
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD$622,760
R01 · FY2020 · AI · contact PI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$168,825
U01 · FY2020 · AI · contact PI
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD$628,494
R01 · FY2019 · AI · contact PI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$168,825
U01 · FY2019 · AI · contact PI
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD$622,106
R01 · FY2018 · AI · contact PI
Reversal of Inflammatory Processes in CGD$396,250
R01 · FY2018 · AI · contact PI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$166,582
U01 · FY2018 · AI · contact PI
Reversal of Inflammatory Processes in CGD$396,250
R01 · FY2017 · AI · contact PI
Reversal of Inflammatory Processes in CGD$396,250
R01 · FY2016 · AI · contact PI
Reversal of Inflammatory Processes in CGD$396,250
R01 · FY2015 · AI · contact PI
Lyso-PS and resolution of acute lung inflammation$285,047
P01 · FY2015 · HL · contact PI
Cell Cuture Core$285,042
P01 · FY2015 · HL · contact PI
Reversal of Inflammatory Processes in CGD$396,250
R01 · FY2014 · AI · contact PI
Lyso-PS and resolution of acute lung inflammation$283,599
P01 · FY2014 · HL · contact PI
Cell Cuture Core$283,596
P01 · FY2014 · HL · contact PI
Cell Cuture Core$275,495
P01 · FY2013 · HL · contact PI
Lyso-PS and resolution of acute lung inflammation$275,494
P01 · FY2013 · HL · contact PI
Cell Cuture Core$289,385
P01 · FY2012 · HL · contact PI
Lyso-PS and resolution of acute lung inflammation$289,385
P01 · FY2012 · HL · contact PI
Macrophage PPARg signaling, efferocytosis, and exaggerated inflammation in CGD$317,000
R56 · FY2011 · AI · contact PI
Cell Cuture Core$293,578
P01 · FY2011 · HL · contact PI
Lyso-PS and resolution of acute lung inflammation$293,578
P01 · FY2011 · HL · contact PI
Phospholipid signaling from apoptotic cells$532,698
P01 · FY2009 · HL · contact PI
Phospholipid signaling from apoptotic cells$514,156
P01 · FY2008 · HL · contact PI
Phospholipid signaling from apoptotic cells$563,152
P01 · FY2007 · HL · contact PI
Defective PS Exposure in Neutrophil Apoptosis in CGD$251,553
R01 · FY2007 · AI · contact PI
Phospholipid signaling from apoptotic cells$378,462
P01 · FY2006 · HL · contact PI
Defective PS Exposure in Neutrophil Apoptosis in CGD$259,066
R01 · FY2006 · AI · contact PI
Phospholipid signaling from apoptotic cells$381,440
P01 · FY2005 · HL
Cell Culture Core$286,570
P01 · FY2005 · HL
Defective PS Exposure in Neutrophil Apoptosis in CGD$265,300
R01 · FY2005 · AI
EOSINOPHILS, APOPTOSIS, AND ASTHMA$264,498
P01 · FY2005 · HL
Defective PS Exposure in Neutrophil Apoptosis in CGD$265,300
R01 · FY2004 · AI
EOSINOPHILS, APOPTOSIS, AND ASTHMA$242,054
P01 · FY2002 · HL
Membrane Phospholipid Distribution/Mediator Translocatio$220,513
P01 · FY2002 · HL
Membrane Phospholipid Distribution/Mediator Translocatio$220,513
P01 · FY2001 · HL
EOSINOPHILS, APOPTOSIS, AND ASTHMA$0
P01 · FY2001 · HL
Membrane Phospholipid Distribution/Mediator Translocatio$220,513
P01 · FY2000 · HL